Hosted on MSN1d
Majestät aus der Luft: Die sieben Hügel Roms aus der Vogelperspektive
Erkunden Sie die legendären Sieben Hügel Roms mit dieser atemberaubenden Drohnenaufnahme und fangen Sie die Schönheit jedes ...
Morningstar6d
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...
Morningstar5d
Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement
CRANBURY, N.J., Feb. 7, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing ...
Yahoo Finance5d
Palatin concludes Phase II trial of combination therapy for obesity
Palatin Technologies has completed its Phase II study, BMT-801, evaluating the joint administration of melanocortin 4 receptor (MC4R) bremelanotide with tirzepatide, a glucagon-like peptide-1 (GLP ...
Finanznachrichten6d
Palatin Technologies, Inc.: Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
Last Patient / Last Visit Completed Topline Data Readout Expected Later This Quarter CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a ...
Business Insider5d
Palatin Technologies Announces $4.7 Mln Direct Offering
(RTTNews) - Palatin Technologies, Inc. (PTN) Friday announced that it has entered into agreements with a healthcare-focused institutional investor for the sale of 4.6 million shares at $1.00 each ...
Business Insider5d
Palatin to sell 4.69M shares at $1.00 in registered direct offering
Palatin (PTN) Technologies announced that it has entered into definitive agreements with a single healthcare focused institutional investor for the purchase and sale of 4,688,000 shares of its ...
Börsennews2d
Palatin Technologies Aktie • Geld 0,883 (2.000 Stk) • Brief 0,939 (2.000 Stk)
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A. Palatin Technologies, Inc. ist ein biopharmazeutisches Unternehmen, das gezielt rezeptorspezifische ...